229 related articles for article (PubMed ID: 9266441)
1. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
Chamberlain MC; Kormanik PR
J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.
Chamberlain MC; Kormanik P
Arch Neurol; 1998 Apr; 55(4):506-12. PubMed ID: 9561978
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal metastases due to melanoma.
Chamberlain M; Kormanik P
Int J Oncol; 1996 Sep; 9(3):505-10. PubMed ID: 21541542
[TBL] [Abstract][Full Text] [Related]
4. Lymphomatous meningitis in immunocompetent patients.
Chamberlain M; Kormanik P
Oncol Rep; 1997; 4(6):1311-8. PubMed ID: 21590244
[TBL] [Abstract][Full Text] [Related]
5. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis.
Chamberlain MC; Dirr L
J Clin Oncol; 1993 Oct; 11(10):1978-84. PubMed ID: 7692000
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
Chamberlain MC; Kormanik PA
Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
[TBL] [Abstract][Full Text] [Related]
9. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
Chamberlain MC; Kormanik P; Glantz M
Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal metastases: a review of evaluation and treatment.
Chamberlain MC
J Neurooncol; 1998 May; 37(3):271-84. PubMed ID: 9524085
[TBL] [Abstract][Full Text] [Related]
11. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Barba D
J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
[TBL] [Abstract][Full Text] [Related]
12. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
13. Combined-modality treatment of leptomeningeal gliomatosis.
Chamberlain MC
Neurosurgery; 2003 Feb; 52(2):324-29; discussion 330. PubMed ID: 12535360
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
16. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant.
Jayson GC; Howell A; Harris M; Morgenstern G; Chang J; Ryder WD
Cancer; 1994 Dec; 74(12):3135-41. PubMed ID: 7982179
[TBL] [Abstract][Full Text] [Related]
17. Neoplastic meningitis.
Chamberlain MC
Neurologist; 2006 Jul; 12(4):179-87. PubMed ID: 16832237
[TBL] [Abstract][Full Text] [Related]
18. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations.
Lee S; Ahn HK; Park YH; Nam DH; Lee JI; Park W; Choi DH; Huh SJ; Park KT; Ahn JS; Im YH
Breast Cancer Res Treat; 2011 Oct; 129(3):809-17. PubMed ID: 21785952
[TBL] [Abstract][Full Text] [Related]
20. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
